Rabbit model for Chlamydia pneumoniae infection.

作者: I W Fong , B Chiu , E Viira , M W Fong , D Jang

DOI: 10.1128/JCM.35.1.48-52.1997

关键词:

摘要: A rabbit model was established for Chlamydia pneumoniae infection that may be helpful to understand the pathogenesis of disease in humans. Twelve, pathogen-free, 1-month-old New Zealand White rabbits were inoculated with 1.0 x 10(7) 5.0 CFU purified C. (ATCC strain VR 1310) via nasopharynx (1 died immediately postinoculation, and 11 available study). Five controls carrier buffer. Ten study demonstrated serological evidence acute (immunoglobulin G antibodies, 1:8 > 1:16), weakest response at 7 days strongest 28 days, whereas none showed any seroconversion. Study animals sacrificed batches three, on 7, 14, 21, 28, but 28. Two-thirds bronchiolitis pneumonia 14 resolution by day 21. Two demonstrated, histology, early intermediate lesions atherosclerosis: one animal (day 7) accumulation foamy macrophages (fatty streak) arch aorta, other 14) spindle cell proliferation smooth muscle cells (intermediate lesion). Focal periaortitis seen same 7). elementary bodies immunocytochemical stain lungs (n = 2), liver 3), spleen 5), aorta which corresponded lesion. cultured from aortic 1). All histopathological, immunocytochemical, cultural studies negative controls. Hence, provides a useful its complications, particularly atherosclerosis.

参考文章(20)
D. L. Patton, T. C. Moazed, L. A. Campbell, C.-C. Kuo, J. T. Grayston, Experimental rabbit models of Chlamydia pneumoniae infection American Journal of Pathology. ,vol. 148, pp. 667- 676 ,(1996)
David H Thom, J Thomas Grayston, David S Siscovick, San-Pin Wang, Noel S Weiss, Janet R Daling, Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease JAMA: The Journal of the American Medical Association. ,vol. 268, pp. 68- 72 ,(1992) , 10.1001/JAMA.1992.03490010070032
E Linnanmäki, M Leinonen, K Mattila, M S Nieminen, V Valtonen, P Saikku, Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. ,vol. 87, pp. 1130- 1134 ,(1993) , 10.1161/01.CIR.87.4.1130
P Patel, M A Mendall, D Carrington, D P Strachan, E Leatham, N Molineaux, J Levy, C Blakeston, C A Seymour, A J Camm, T C Northfield, Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors BMJ. ,vol. 311, pp. 711- 714 ,(1995) , 10.1136/BMJ.311.7007.711
J. T. Grayston, L. A. Campbell, C.-C. Kuo, C. H. Mordhorst, P. Saikku, D. H. Thorn, S.-P. Wang, A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWAR The Journal of Infectious Diseases. ,vol. 161, pp. 618- 625 ,(1990) , 10.1093/INFDIS/161.4.618
Sandra L. Melnick, Eyal Shahar, Aaron R. Folsom, J.Thomas Grayston, Paul D. Sorlie, San-Pin Wang, Moyses Szklo, Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis The American Journal of Medicine. ,vol. 95, pp. 499- 504 ,(1993) , 10.1016/0002-9343(93)90332-J
Suvi-Sirkku E. Kaukoranta-Tolvanen, Aino L. Laurila, Pekka Saikku, Maija Leinonen, Kirsi Laitinen, Experimental Chlamydia pneumoniae infection in mice: Effect of reinfection and passive immunization Microbial Pathogenesis. ,vol. 18, pp. 279- 288 ,(1995) , 10.1016/S0882-4010(05)80004-X
T. J. Marrie, Community-acquired pneumonia Clinical Infectious Diseases. ,vol. 18, pp. 501- 515 ,(1994) , 10.1093/CLINIDS/18.4.501
C.-c. Kuo, A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, J. T. Grayston, Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries The Journal of Infectious Diseases. ,vol. 167, pp. 841- 849 ,(1993) , 10.1093/INFDIS/167.4.841